| Ytd | -18.19% | |
| 1y | -19.36% |
| Open | 36.76 | Prev Close | 36.76 | Low | 36.51 | High | 37.06 | Mkt Cap | 5.23B |
| Vol | 39.97K | Avg Vol | 2.04M | EPS | 4.86 | P/E | 7.60 | Forward P/E | 6.65 |
| Beta | N/A | Short Ratio | 1.71 | Inst. Own | 83.88% | Dividend | 1.50 | Div Yield | 3.92 |
| Ex Div Date | 10-01 | Earning | 08-06 | 50-d Avg | 37.62 | 200-d Avg | 37.57 | 1yr Est | 44.33 |
Empowered Funds LLC bought a new stake in shares of Versant Corporation (NASDAQ: VSNT) in the undefi
Versant NASDAQ: VSNT reported second-quarter revenue of $1.64 billion, down 4% from the prior-year p
Versant Media Group, Inc. (VSNT) Q2 2026 Earnings Call Transcript
Versant Media shares climbed after the company raised its full-year outlook despite recording lower
Versant delivered mixed results in its second quarter after spinning off from Comcast, with revenue
Versant Media raised its annual revenue forecast on Thursday as higher advertising sales, driven by
Versant, Comcast's recently spun out portfolio of pay TV networks and digital properties like Fandan
NEW YORK--(BUSINESS WIRE)--Versant Media Group, Inc. (Nasdaq: VSNT) (the “Company”) today reported o
GRAPEVINE, Texas--(BUSINESS WIRE)--Versant Diagnostics has acquired American Dermatopathology Labora